L'institut Domaines de recherche Plates-formes techniques Venir à l'INM. Pourquoi? Actu / presse

U844

 

U1051

Equipe 1
Génétique et thérapies des cécités rétiniennes et du nerf optique

Equipe 2
Surdité, acouphènes et thérapies

Equipe 3
Différentiation neurale et connectivité dans le système
somato-sensoriel

Equipe 4
Plasticité, cellules souches et gliomes

Equipe 5 (en cours)
Pathologie du motoneurone : voies de signalisation et thérapies

Equipe Avenir 1
Spécification somato-sensorielle

Equipe Avenir 2
Myélinisation/démyélinisation dans le système nerveux

Equipe Avenir 3
Le système Ubiquitine Protéasome dans la neurodégénérescence et l'architecture du cytosquelette

 

| Accueil | Contact | Légal |    

Guy Lenaers

Function : CR CNRS, Group Leader : inherited optic neuropathies and mitochondrial disorders

 

Academic and research track :

I graduate in 1985 in Toulouse from the DEA Biologie et Santé (Université Paul Sabatier), then went to the marine station of Banyuls sur Mer to study dinoflagelatte phylogeny in Luc Maroteaux, Marie-Odile Soyer-Gobillard and Michel Herzog group. I read my thesis in 1990, at Université Montpellier II and went as a post-doctorate in Paul Russell lab at Scripps Clinic Research Institute (San Diego, CA, USA) to study fission yeast cell cycle regulation by tyrosine phosphatases. In 1992, I was recruited by the CNRS and joined André Picard group in Banyuls sur Mer, to study fission yeast gene expression along the cell cycle. In 1999, I moved to Bernard Ducommun laboratory in Toulouse and started to study mitochondrial dynamic, uncovering OPA1 and its involvement in Dominant Optic Atrophy. In 2003, I obtained my « Habilitation à Diriger les Recherches » from the Université de Toulouse. In 2004, I started my group in Christian Hamel department at the “Institut des Neurosciences de Montpellier”.

 

Main achievements :

• During my post doctoral fellowship, I uncovered the role of the tyrosine phosphatases cdc25 and pyp3 in the control of the G2/M transition of the cell cycle.
• In 2000, I contributed to show that the mitochondrial dynamin-related protein, OPA1, is responsible for the majority of cases of Kjer disease, one of the leading cause of inherited optic neuropathy.
• Recently, we identified a novel gene OPA7 involved in a form of syndromic Dominant Optic Atrophy.

 

Research interests :

• Discovering the genes causing inherited diseases of the optic nerve, for their extraordinary potential to improve our understanding of the mitochondrial physiology and pathophysiology in the optic nerve function.
• Studying the the natural history of inherited optic neuropathies and understanding why retinal ganglion cells are susceptible to certain mitochondrial defects and how we can act on mitochondrial metabolism to restore their functional integrity.
• Understanding the roles of OPA genes in the dynamic and structure of the mitochondrial inner membrane that support the respiratory complexes.
• Using this knowledge to provide accurate genetic counselling and design neuroprotective strategies to treat patients and prevent low vision and blindness.

 

Selected publications :

Original publications :

Olichon A, Elachouri G, Baricault L, Delettre C, Belenguer P, Lenaers G.
OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis.
Cell Death Differ. 2007 Apr;14(4):682-92.

Reynier P, Amati-Bonneau P, Verny C, Olichon A, Simard G, Guichet A, Bonnemains C, Malecaze F, Malinge MC, Pelletier JB, Calvas P, Dollfus H, Belenguer P, Malthiery Y, Lenaers G, Bonneau D.
OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.
J Med Genet. 2004 Sep;41(9):e110.

Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G.
Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.
J Biol Chem. 2003 Mar 7;278(10):7743-6.

Lenaers G, Delettre C, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP.
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.
Nat Genet. 2000 Oct;26(2):207-10.

 

Reviews :

Delettre C, Hamel CP, Lenaers G.
Optic Atrophy, Type I.
http://www.genetests.org/servlet/access?id=&key=&fcn=y&fw=Nif0&filename=/profiles/opa/index.html.
NIH  •  University of Washington, Seattle, July 2007.

Hamel CP, Lenaers G.
Les neuropathies optiques héréditaires
Encyclopédie Médicale Continue 21-480-E-30, Juillet 2007.

Olichon A, Guillou E, Delettre C, Landes T, Arnaune-Pelloquin L, Emorine LJ, Mils V, Daloyau M, Hamel C, Amati-Bonneau P, Bonneau D, Reynier P, Lenaers G, Belenguer P.
Mitochondrial dynamics and disease, OPA1.
Biochim Biophys Acta. 2006 May-Jun;1763(5-6):500-9.

 

Other fonctions :

Membre of Médecins Sans Frontières:
                Head of a tuberculosis diagnosis laboratory in the Afar Region, Ethiopia (dec 2003- may 2004).

Membre of Comité de Secours Internationaux :
                Head of a medical rescue team in Pakistan Cachmira earthquake (oct 2005).

 

Haut de la page

L'institut | Domaines de recherche | Plates-formes techniques |
Venir à l'INM. Pourquoi? | Actu / Presse | Contact |
Accueil | Site map |  Légal & crédits
Directeur de publication: Christian Hamel
Copyright © INM 2006